Identification of a Novel Mutation in the SERPINE1 Gene Causing Clinical Hyperfibrinolysis in English Springer Spaniel Dogs
- PMID: 40470612
- PMCID: PMC12138437
- DOI: 10.1111/jvim.70150
Identification of a Novel Mutation in the SERPINE1 Gene Causing Clinical Hyperfibrinolysis in English Springer Spaniel Dogs
Abstract
Background: A 7-month-old female spayed English Springer Spaniel (ESS) was evaluated for spontaneous hemoperitoneum. Hyperfibrinolysis was identified on thromboelastography.
Hypothesis/objectives: To identify a genetic mutation causing congenital hyperfibrinolysis in the proband and evaluate the prevalence of the mutation in the ESS breed.
Animals: Client-owned ESS with hemorrhage and a non-affected littermate. Samples of DNA from 3 ESS, 1 Welsh Springer Spaniel (WSS) with unexplained hemorrhage, and 199 ESS with no history of hemorrhage.
Methods: Whole genome sequencing (WGS) of the proband with variant filtering against an in-house WGS database of 671 presumably unaffected dogs identified a deleterious variant of SERPINE1 unique to the proband, which encodes for plasminogen activator inhibitor 1 (PAI-1). SERPINE1 was genotyped in the remaining animal population by Sanger sequencing or a Taqman assay. Liquid chromatography tandem mass spectrometry (LC-MS/MS) was performed on platelet pellets from the proband, a littermate, and three unrelated healthy ESS.
Results: Whole genome sequencing of the proband identified a unique homozygous insertion at chr6:8640592 in exon 1 of SERPINE1, which is predicted to cause a premature stop codon. The unaffected littermate was heterozygous for the mutation. Two unrelated ESS and 1 WSS with post-operative hemorrhage were homozygous for the mutation. Absence of PAI-1 in the proband's platelets was documented using LC-MS/MS.
Conclusions and clinical importance: This novel mutation in SERPINE1 is associated with the absence of the PAI-1 protein in platelets and might cause hemorrhage because of hyperfibrinolysis in ESS and related breeds.
Keywords: coagulation; delayed postoperative hemorrhage; plasminogen activator inhibitor‐1; whole genome sequencing.
© 2025 The Author(s). Journal of Veterinary Internal Medicine published by Wiley Periodicals LLC on behalf of American College of Veterinary Internal Medicine.
Conflict of interest statement
Steven G. Friedenberg serves as Associate Editor for the Journal of Veterinary Internal Medicine. He was not involved in the review of this manuscript. The other authors declare no conflicts of interest.
Figures

Similar articles
-
Characterization of the genetic basis for autosomal recessive hereditary nephropathy in the English Springer Spaniel.J Vet Intern Med. 2012 Mar-Apr;26(2):294-301. doi: 10.1111/j.1939-1676.2012.00888.x. Epub 2012 Feb 28. J Vet Intern Med. 2012. PMID: 22369189
-
Deafness and vestibular dysfunction in a Doberman Pinscher puppy associated with a mutation in the PTPRQ gene.J Vet Intern Med. 2018 Mar;32(2):665-669. doi: 10.1111/jvim.15060. Epub 2018 Feb 20. J Vet Intern Med. 2018. PMID: 29460419 Free PMC article.
-
A de novo mutation in the EXT2 gene associated with osteochondromatosis in a litter of American Staffordshire Terriers.J Vet Intern Med. 2018 May;32(3):986-992. doi: 10.1111/jvim.15073. Epub 2018 Feb 27. J Vet Intern Med. 2018. PMID: 29485212 Free PMC article.
-
Life-threatening hemorrhage and prolonged wound healing are remarkable phenotypes manifested by complete plasminogen activator inhibitor-1 deficiency in humans.J Thromb Haemost. 2011 Jun;9(6):1200-6. doi: 10.1111/j.1538-7836.2011.04288.x. J Thromb Haemost. 2011. PMID: 21486382
-
Complete Plasminogen Activator Inhibitor 1 Deficiency.2017 Aug 3 [updated 2023 Feb 23]. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2025. 2017 Aug 3 [updated 2023 Feb 23]. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2025. PMID: 28771291 Free Books & Documents. Review.
References
-
- Birkbeck R., Humm K., and Cortellini S., “A Review of Hyperfibrinolysis in Cats and Dogs,” Journal of Small Animal Practice 60 (2019): 641–655. - PubMed
-
- Gils A. and Declerck P. J., “Plasminogen Activator Inhibitor‐1,” Current Medicinal Chemistry 11 (2004): 2323–2334. - PubMed
-
- Fay W. P., Shapiro A. D., Shih J. L., Schleef R. R., and Ginsburg D., “Complete Deficiency of Plasminogen‐Activator Inhibitor Type 1 due to a Frameshift Mutation,” New England Journal of Medicine 327 (1992): 1729–1733. - PubMed
-
- Iwaki T., Tanaka A., Miyawaki Y., et al., “Life‐Threatening Hemorrhage and Prolonged Wound Healing Are Remarkable Phenotypes Manifested by Complete Plasminogen Activator Inhibitor‐1 Deficiency in Humans,” Journal of Thrombosis and Haemostasis 9, no. 6 (2011): 1200–1206, 10.1111/j.1538-7836.2011.04288.x. - DOI - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous